Cigarette consumption and sales of nicotine replacement products
Open Access
- 1 June 2000
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 9 (90002) , 60ii-63
- https://doi.org/10.1136/tc.9.suppl_2.ii60
Abstract
BACKGROUND The first nicotine replacement product, Nicorette Gum, was marketed in 1984 as an adjuvant to help smokers quit smoking. In 1992, sales of nicotine patches were begun. Before 1996, nicotine gums and nicotine patches were prescribed by physicians and supplemented with behavioural counselling. Since 1996, nicotine gums and patches became available over the counter. OBJECTIVES To examine the effect of sales of nicotine replacement products on national cigarette consumption. DESIGN National time series quarterly cigarette consumption, sales of nicotine gums and patches data between 1976 and 1998 are used to estimate a time series autoregressive moving average intervention model. PARTICIPANTS National reported statistics. MAIN OUTCOME MEASURES Per capita cigarette sales. RESULTS A 10% increase in sales of nicotine replacement products will lead to a 0.04% reduction in cigarette sales. The model indicates that a 0.076% reduction in cigarette consumption is associated with the availability of nicotine patches after 1992. The over the counter dummy variable (after 1996) has a negative sign, but is not significant, perhaps due to only a few quarters of data in the study period. CONCLUSIONS Nicotine replacement products (nicotine gums and nicotine patches) play a significant role in reducing cigarette consumption, in addition to the negative effect of increasing cigarette price and the overall trend of declining cigarette consumption (as reflected by the time trend variable). The findings of this study suggest that additional efforts for promoting sales of nicotine replacement products will be another effective alternative to discouraging cigarette consumption.Keywords
This publication has 14 references indexed in Scilit:
- Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research.1997
- Treating Tobacco Addiction — Nicotine or No Nicotine?New England Journal of Medicine, 1997
- The Emerging Market for Long-term Nicotine MaintenanceJAMA, 1997
- Cost-effectiveness of the Transdermal Nicotine Patch as an Adjunct to Physicians' Smoking Cessation CounselingJAMA, 1996
- Nicotine Patch Use in the General Population: Results From the 1993 California Tobacco SurveyJNCI Journal of the National Cancer Institute, 1995
- Combined Use of Nicotine Patch and Gum in Smoking Cessation: A Placebo-Controlled Clinical TrialPreventive Medicine, 1995
- Predicting smoking cessation. Who will quit with and without the nicotine patchJAMA, 1994
- Tobacco dependence and the nicotine patch. Clinical guidelines for effective use.1992
- A Double-Blind Trial of a 16-Hour Transdermal Nicotine Patch in Smoking CessationNew England Journal of Medicine, 1991
- Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.1991